MULE', Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 19.352
EU - Europa 13.096
AS - Asia 3.531
AF - Africa 194
SA - Sud America 48
Continente sconosciuto - Info sul continente non disponibili 31
OC - Oceania 14
Totale 36.266
Nazione #
US - Stati Uniti d'America 19.320
IT - Italia 6.054
FI - Finlandia 2.488
CN - Cina 1.915
UA - Ucraina 1.616
SG - Singapore 1.207
DE - Germania 629
IE - Irlanda 597
GB - Regno Unito 397
RU - Federazione Russa 290
SE - Svezia 259
FR - Francia 195
CI - Costa d'Avorio 172
RO - Romania 159
BE - Belgio 152
IN - India 109
KR - Corea 85
NL - Olanda 70
IR - Iran 46
PL - Polonia 46
CH - Svizzera 39
BR - Brasile 35
EU - Europa 29
TR - Turchia 28
CA - Canada 23
ES - Italia 22
JP - Giappone 20
GR - Grecia 19
HK - Hong Kong 19
TW - Taiwan 15
UZ - Uzbekistan 14
ID - Indonesia 13
LB - Libano 13
AT - Austria 12
AU - Australia 11
CZ - Repubblica Ceca 10
PK - Pakistan 8
EG - Egitto 7
IL - Israele 7
AL - Albania 6
IQ - Iraq 5
NG - Nigeria 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
VN - Vietnam 5
BD - Bangladesh 4
CL - Cile 4
CO - Colombia 4
HR - Croazia 4
HU - Ungheria 4
MX - Messico 4
PH - Filippine 4
PT - Portogallo 4
TH - Thailandia 4
TN - Tunisia 4
DK - Danimarca 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
BG - Bulgaria 2
MY - Malesia 2
MZ - Mozambico 2
NP - Nepal 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AN - Antille olandesi 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GL - Groenlandia 1
HT - Haiti 1
LU - Lussemburgo 1
MV - Maldive 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
SD - Sudan 1
SM - San Marino 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 36.266
Città #
Fairfield 2.250
Ashburn 1.870
Chandler 1.637
Woodbridge 1.485
Houston 1.253
Wilmington 1.181
Ann Arbor 1.094
Singapore 985
Seattle 879
Jacksonville 860
Cambridge 749
Palermo 677
Dublin 593
Medford 573
Nanjing 386
Princeton 367
Des Moines 335
Milan 313
Dearborn 281
New York 265
Rome 263
Altamura 241
Tulsa 218
Beijing 201
Lawrence 177
Abidjan 172
San Diego 151
Brussels 150
Santa Clara 150
Hebei 148
Boardman 141
Shenyang 140
Nanchang 135
Jinan 132
Ludwigshafen am Rhein 123
Changsha 122
Cagliari 118
Tianjin 84
Monreale 77
Turin 77
Jiaxing 75
Seongnam 75
Favara 72
Naples 70
Saint Petersburg 64
Kumar 61
San Mateo 61
Ningbo 59
Zhengzhou 58
Catania 55
Verona 51
Helsinki 49
London 47
Hangzhou 45
Venice 45
Columbus 44
Düsseldorf 42
Guangzhou 42
Redwood City 41
Bologna 39
Falls Church 38
Florence 38
Oristano 36
Los Angeles 35
Taizhou 35
Haikou 34
Orange 32
San Paolo di Civitate 32
Munich 31
Taiyuan 31
Washington 28
Auburn Hills 27
Tehran 27
Parma 26
Napoli 23
Padova 22
Genoa 21
Pune 21
Bremen 20
Kraków 20
Phoenix 19
Santa Venerina 18
Dallas 17
Indiana 17
Izmir 17
Marsala 17
Fuzhou 16
Norwalk 16
Novara 16
Redmond 16
Hefei 15
Oniferi 15
Sassari 15
Tappahannock 15
Kilburn 14
Bari 13
Lanzhou 13
Paris 13
Chicago 12
Colchester 12
Totale 23.031
Nome #
UN ELEVATO RAPPORTO NEUTROFILI-LINFOCITI AUMENTA IL RISCHIO DI EVENTI CARDIOVASCOLARI E DI DECLINO DELLA FUNZIONE RENALE IN UNA COORTE DI PAZIENTI IPERTESI NEFROPATICI 2.235
Relazioni tra stiffness aortica ed indice di resistenza intrarenale nell’ipertensione arteriosa 364
Association of Renal Resistive Index with Markers of Extrarenal Vascular Changes in Patients with Systemic Lupus Erythematosus 249
CORRELAZIONE TRA ALDOSTERONE E PARATORMONE PLASMATICI NELL’IPERTENSIONE ARTERIOSA ESSENZIALE 226
[OP.5C.05] SERUM URIC ACID IS INCREASED IN NORMOTENSIVE OBESE CHILDREN WITH A PARENTAL HYSTORY OF HYPERTENSION 222
Association of renal resistive index with aortic pulse wave velocity in hypertensive patients 214
Association Between Uric Acid and Renal Hemodynamics: Pathophysiological Implications for Renal Damage in Hypertensive Patients 185
Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects 178
The Association of Microalbuminuria With Aortic Stiffness Is Independent of C-Reactive Protein in Essential Hypertension 177
How common is isolated nocturnal hypertension? 174
Relationships between mild hyperuricaemia and aortic stiffness in untreated hypertensive patients 173
Association between early-stage chronic kidney disease and reduced choroidal thickness in essential hypertensive patients 172
Renal haemodynamics and severity of carotid atherosclerosis in hypertensive patients with and without impaired renal function 171
Vitamina D, ipertensione arteriosa e sistema renina-angiotensina 171
ASSOCIATION OF RENAL RESISTIVE INDEX WITH AORTIC PULSE WAVE VELOCITY IN HYPERTENSIVE PATIENTS. 171
AORTIC STIFFNESS IS INCREASED IN NORMOTENSIVE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS 169
Plasma aldosterone and its relationships with left ventricular mass in essential hypertensive patients with the metabolic syndrome 167
Clinical correlates of renal dysfunction in hypertensive patients without cardiovascular complications: the REDHY study. 167
Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease 167
EFFETTI DELL'ALLOPURINOLO SUL DECLINO DEL FILTRATO GLOMERULARE IN PAZIENTI IPERTESI CON INSUFFICIENZA RENALE CRONICA 167
Absence of an independent association between serum uric acid and left ventricular mass in Caucasian hypertensive women and men 166
Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients 165
Unfavourable interaction of microalbuminuria and mildly reduced creatinine clearance on aortic stiffness in essential hypertension 164
Relationship Between Carotid Atherosclerosis and Pulse Pressure with Renal Hemodynamics in Hypertensive Patients 163
[OP.7B.08] INFLUENCE OF GENDER ON THE RELATIONSHIPS BETWEEN NEW INDICES OF ADIPOSITY AND LEFT VENTRICULAR MASS AND HYPERTROPHY IN HYPERTENSIVE PATIENTS 163
INFLUENCE OF THE METABOLIC SYNDROME ON AORTIC STIFFNESS IN NEVER TREATED HYPERTENSIVE PATIENTS 160
Retinal and choroidal vasculature changes associated with chronic kidney disease 158
Metabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and function 158
Vitamin D receptor gene polymorphisms and plasma renin activity in essential hypertensive individuals 157
Blood Pressure control by 24-hour Ambulatory Monitoring in Chronic Renal Failure. 157
Electrocardiography for Assessment of Hypertensive Heart Disease: A New Role for an Old Tool 156
La disfunzione renale nell’ipertensione arteriosa 155
Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients 153
The Relationship between an Oxidative Stress Biomarker and Plasma Haemoglobin in Patients with Chronic Kidney Disease 153
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 152
Relationship of metabolic syndrome with pulse pressure in patients with essential hypertension 151
Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria 149
Retinal vascular imaging in cardiovascular medicine: New tools for an old examination 149
SERUM URIC ACID IS INCREASED IN NORMOTENSIVE OBESE CHILDREN WITH A PARENTAL HYSTORY OF HYPERTENSION 148
Renal involvement in psychological eating disorders 147
Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial). 145
Relation of C-reactive protein to oxidative stress and to endothelial activation in essential hypertension. 145
Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram 145
C-reactive protein and intercellular adhesion molecule-1 are stronger predictors of oxidant stress than blood pressure in established hypertension 143
[OP.3B.03] INFLUENCE OF SUBCLINICAL RENAL DAMAGE ON EARLY VASCULAR AGING IN PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS 143
RELATIONSHIPS BETWEEN PLASMA ALDOSTERONE LEVELS AND LEFT VENTRICULAR MASS AND GEOMETRY IN ESSENTIAL HYPERTENSIVE PATIENTS: DOES SEX MATTER? 143
Usefulness of microalbuminuria in cardiovascular risk stratification of essential hypertensive patients 143
Influence of metabolic syndrome on hypertension-related target organ damage 141
Impact of type 2 diabetes on left ventricular geometry and diastolic function in hypertensive patients with chronic kidney disease 141
INVERSE RELATIONSHIPS BETWEEN CHOROIDAL THICKNESS AND RENAL RESISTANCE INDEX IN HYPERTENSIVE PATIENTS 141
Relationship between aortic root size and glomerular filtration rate in hypertensive patients 140
Inverse relationship between ambulatory arterial stiffness index and glomerular filtration rate in arterial hypertension 139
Parathyroid hormone is inversely related to endothelin-1 in patients on haemodialysis 138
Average real variability of 24-h systolic blood pressure is associated with microalbuminuria in patients with primary hypertension 137
[OP.2D.05] RELATIONSHIP OF OXIDATIVE STRESS WITH CARDIAC HYPERTROPHY IN HYPERTENSIVE PATIENTS 137
[PP.07.19] ASSOCIATION OF MAXIMUM SPEED OF BLOOD PRESSURE RISE DURING 24-H ABPM WITH SUBCLINICAL RENAL DAMAGE IN ESSENTIAL HYPERTENSION 137
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 137
A low reported energy intake is associated with metabolic syndrome. 135
Serum uric acid is not independently associated with plasma renin activity and plasma aldosterone in hypertensive adults 135
Electrocardiography plus limited echocardiography in young, newly identified, hypertensives: some considerations. 134
ASSOCIATION OF RENAL RESISTIVE INDEX WITH MARKERS OF EXTRARENAL VASCULAR CHANGES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS 134
Hyperuricemia and high blood pressure at rest and during exercise: Guilty or innocent? The jury is still out 134
Left ventricular hypertrophy: not so much determinant of renal outcome? 133
Association between uric acid and renal function in hypertensive patients: Which role for systemic vascular involvement? 133
Relationships between metabolic syndrome and left ventricular mass in hypertensive patients: does sex matter? 133
I nutraceutici nell'ipertensione 132
[OP.4B.03] CIRCULATING ALDOSTERONE LEVELS ARE ASSOCIATED WITH CONCENTRIC LEFT VENTRICULAR GEOMETRY IN ESSENTIAL HYPERTENSIVE PATIENTS 132
Circulating levels of molecular adhesion correlate with stage of renal disease and C-reactive protein in chronic kidney disease 131
Inflammation and Aortic Pulse Wave Velocity: A Multicenter Longitudinal Study in Patients With Inflammatory Bowel Disease 131
Renal haemodynamics and coronary atherosclerotic burden are associated in patients with hypertension and mild coronary artery disease 131
Relationship between ambulatory artery stiffness index and glomerular filtration rate in essential hypertension 129
Relationship Between Short-Term Blood Pressure Variability and Subclinical Renal Damage in Essential Hypertensive Patients 129
Inappropriately high left ventricular mass: Marker of very high cardiovascular risk in patients with chronic kidney disease 129
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 129
Relationship between kidney findings and systemic vascular damage in elderly hypertensive patients without overt cardiovascular disease 129
The Unsolved Conundrum of Optimal Blood Pressure Target During Acute Haemorrhagic Stroke: A Comprehensive Analysis 125
Choroidal thickness is associated with renal hemodynamics in essential hypertension 125
INFLUENCE OF DIFFERENT METHODS TO ESTIMATE THE GLOMERULAR FILTRATION RATE ON THE PREVALENCE OF DECREASED RENAL FUNCTION IN ARTERIAL HYPERTENSION. 124
The nephroprotective effect of sacubitril/valsartan in heart failure: insights from the real-life clinical setting 124
Impact of metabolic syndrome on left ventricular mass: is the same in all ethnic groups and in men and women?. Reply. 123
The renal resistive index: is it a misnomer? 123
PLASMA ENDOTHELIN-1 IS ASSOCIATED WITH AORTIC STIFFNESS IN ESSENTIAL HYPERTENSION 122
Plasma aldosterone and its relationship with left ventricular mass in hypertensive patients with early-stage chronic kidney disease 122
Para-perirenal distribution of body fat is associated with reduced glomerular filtration rate regardless of other indices of adiposity in hypertensive patients 122
Relationship of a Body Shape Index and Body Roundness Index with carotid atherosclerosis in arterial hypertension 122
The prognostic role of the cardio-ankle vascular index 122
The Metabolic Syndrome as a Prohypertensive State. 121
The metabolic syndrome-arterial stiffness relationship in patients with ischaemic stroke: role of inflammation 121
Influence of gender on the relation between the metabolic syndrome and left ventricular mass 121
LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS WITH NORMAL ELECTROCARDIOGRAM 120
Subclinical atherosclerosis and fetuin-A plasma levels in essential hypertensive patients. 120
Impact of the metabolic syndrome on total arterial compliance in essential hypertension patients 119
Metabolic syndrome in hypertensive patients: An unholy alliance 119
Inflammation and endothelial activation are linked to renal function in long-term kidney transplantation 118
RELATIONSHIP BETWEEN OXIDATIVE STRESS AND AORTIC STIFFNESS IN HYPERTENSIVE PATIENTS WITH CHRONIC KIDNEY DISEASE 118
Nitric oxide metabolites and oxidative stress in mild essential hypertension 117
The Association of Microalbuminuria With Aortic Stiffness is Independent of C-Reactive Protein in Essential Hypertension 116
Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function 115
INFLUENCE OF HIV INFECTION AND ANTIRETROVIRAL THERAPY ON AORTIC STIFFNESS 115
Attivazione endoteliale in pazienti ipertesi non microalbuminurici 114
Totale 16.819
Categoria #
all - tutte 127.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.582


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.656 0 0 0 0 0 955 834 473 807 363 844 380
2020/20214.305 193 436 284 427 381 180 364 229 562 356 442 451
2021/20223.821 150 853 89 146 111 164 150 191 507 435 236 789
2022/20235.026 662 780 158 504 509 835 278 332 557 58 249 104
2023/20243.766 144 380 179 508 275 649 274 293 115 250 213 486
2024/20253.380 318 672 908 765 403 314 0 0 0 0 0 0
Totale 37.451